Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results

Mashup Score: 194

medRxiv - BACKGROUND WHO expert groups recommended mortality trials in hospitalized COVID-19 of four re-purposed antiviral drugs. METHODS Study drugs were Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir) and Interferon-β1a (mainly subcutaneous; initially with Lopinavir, later not). COVID-19 inpatients were randomized equally between whichever study drugs were locally...

Read the full article here

Related Content